Trial intelligence / Profile preview

Streptokinase in acute pulmonary embolism

IRCT201104245625N2Phase 3Completed

Sponsor
Tehran Heart Center
Start
Mar 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of streptokinase in pulmonary embolism (PE), sponsored by Tehran Heart Center. Started Mar 2011; status: completed.

02

Drugs

streptokinase
03

Conditions

pulmonary embolism (PE)

Beyond the preview

Go deeper on IRCT201104245625N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201104245625N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call